Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Australia) · Australia

Jiann-Shiun Lai

Jiann-Shiun Lai publishes mostly in Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research and Cancer Research and Treatments.

OpenAlex
World rank
#3,929,425
of 7,710,434 ranked researchers
Rank in Australia
#99,319
of 140,210
Works
28
Citations
560
Citations per work
20.0
h-index
9
i10-index 9Top 82% in Molecular Biology
Jiann-Shiun Lai

What does Jiann-Shiun Lai research?

Jiann-Shiun Lai's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (19%), Immunology and Microbiology (13%).

Life Sciences: 15 works · 54.0% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 41.3% of their workMolecular Biology: 8 works · 30.2% of their workBiotechnology: 2 works · 7.9% of their workGenetics: 1 works · 3.2% of their workImmunology and Microbiology: 4 works · 12.7% of their workImmunology: 4 works · 12.7% of their workEverything else: 8 works · 27.0% of their workHealth Sciences: 5 works · 19.0% of their workMedicine: 5 works · 19.0% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 11.1% of their workOncology: 2 works · 7.9% of their workTHEIR WORKJiann-Shiun Lai28works
Life Sciences54%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1241.3%
    2. Immunology and Microbiology412.7%
  2. Everything else827.0%
    1. Medicine519.0%
  1. 1Molecular Biology30% of their works
  2. 2Immunology13% of their works
  3. 3Radiology, Nuclear Medicine and Imaging11% of their works
  4. 4Oncology8% of their works
  5. 5Biotechnology8% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Jiann-Shiun Lai's research?

The keywords of their largest research topics: Glycosylation, Cancer, Glycans, Immune System, Immunotherapy, Tumor Regression, Fc Receptors and Therapeutic Antibodies.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Glycosylation172 topics
  2. Cancer132 topics
  3. Glycans101 topic
  4. Immune System101 topic
  5. Immunotherapy82 topics
  6. Tumor Regression82 topics
  7. Fc Receptors71 topic
  8. Therapeutic Antibodies71 topic
  9. Gene Therapy62 topics
  10. Bacterial Therapy41 topic
  11. CAR T Cells41 topic
  12. Chimeric Antigen Receptor41 topic
  13. Tumor Targeting41 topic
  14. Galectins31 topic
  15. Immune Regulation31 topic
  16. AAV21 topic
  17. NK Cell Recognition21 topic
  18. Nanosensors21 topic
  19. Nanowire21 topic
  20. Natural Killer Cells21 topic
  21. Viral Vectors21 topic

Where does Jiann-Shiun Lai work?

Jiann-Shiun Lai's main affiliation in the publication record is Leo Pharma (Australia), Australia.

How many publications and citations does Jiann-Shiun Lai have?

OpenAlex counts 28 works and 560 citations for Jiann-Shiun Lai, an h-index of 9, ranking #3,929,425 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jiann-Shiun Lai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.